|
CEPT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.179800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.989700E-02 |
| Normal-vs-Stage2 |
1.40640000001468E-06 |
| Normal-vs-Stage3 |
7.71000000000521E-05 |
| Normal-vs-Stage4 |
9.191700E-04 |
| Stage1-vs-Stage2 |
2.992800E-04 |
| Stage1-vs-Stage3 |
7.602000E-03 |
| Stage1-vs-Stage4 |
3.097900E-02 |
| Stage2-vs-Stage3 |
1.297640E-01 |
| Stage2-vs-Stage4 |
2.315400E-01 |
| Stage3-vs-Stage4 |
8.965800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.973200E-04 |
| Normal-vs-AfricanAmerican |
1.241690E-02 |
| Normal-vs-Asian |
3.319000E-01 |
| Caucasian-vs-AfricanAmerican |
3.241400E-01 |
| Caucasian-vs-Asian |
1.013600E-01 |
| AfricanAmerican-vs-Asian |
7.257800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.483290E-03 |
| Normal-vs-Female |
5.416500E-04 |
| Male-vs-Female |
8.230400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.212160E-01 |
| Normal-vs-Age(41-60Yrs) |
1.398670E-04 |
| Normal-vs-Age(61-80Yrs) |
1.93799999999023E-05 |
| Normal-vs-Age(81-100Yrs) |
1.639030E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.043500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.835900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.176400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.729800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.078200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.212200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.421900E-02 |
| Classical-VS-Follicular |
1.121860E-02 |
| Classical-VS-Other |
3.334000E-01 |
| Classical-VS-Normal |
4.188200E-02 |
| Tall-VS-Follicular |
9.909600E-01 |
| Tall-VS-Other |
6.340200E-02 |
| Tall-VS-Normal |
1.215110E-03 |
| Follicular-VS-Other |
1.214760E-01 |
| Follicular-VS-Normal |
2.583500E-04 |
| Other-VS-Normal |
8.872000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.65379999999394E-05 |
| Normal-vs-N1 |
6.139400E-03 |
| N0-vs-N1 |
7.113800E-01 |
|
|
